SCHEMBL6938240

SCHEMBL6938240

CCCc1c(OCc2ccccc2)ccc(C(=O)OC)c1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSD P07339 2/20 0.48
FFAR4 Q5NUL3 1/20 0.46
HPGD P15428 2/20 0.46
LMNA P02545 1/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
PKM P14618 1/20 0.45
SMPD1 P17405 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
PDE4D Q08499 1/20 0.44
MAPT P10636 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MTNR1A P48039 1/20 0.44
MTNR1B P49286 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6936538 0.90 PTGER1 (0.50) CTSDHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL6933646 0.88 LTB4R (0.52) CTSDHPGDLMNANPC1RAB9A
SCHEMBL19705426 0.86 CTSD (0.46) CTSDFFAR4HPGDLMNANPC1
SCHEMBL6933049 0.86 CTSD (0.58) CTSDHPGDLMNASMN1; SMN2MAPT
SCHEMBL8675351 0.82 FFAR4 (0.44) FFAR4HPGDLMNANPC1RAB9A
SCHEMBL23611725 0.82 NPC1 (0.60) HPGDLMNANPC1RAB9ASMN1; SMN2
SCHEMBL29930885 0.82 NPC1 (0.60) HPGDLMNANPC1RAB9ASMN1; SMN2
SCHEMBL19704875 0.81 SMN1; SMN2 (0.49) FFAR4HPGDLMNANPC1RAB9A
SCHEMBL19610526 0.80 HPGD (0.57) FFAR4HPGDLMNANPC1RAB9A
SCHEMBL24379471 0.80 MAPT (0.54) HPGDLMNANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888278-B1 ANTIDIABETIC AGENTS MERCK & CO INC (US) 2003-07-23 EP disclosed
EP-0888278-A4 ANTIDIABETIC AGENTS MERCK & CO INC (US) 1999-06-30 EP disclosed
EP-0888278-A1 ANTIDIABETIC AGENTS Merck & Co., Inc. (US) 1999-01-07 EP disclosed
WO-1997028115-A1 ANTIDIABETIC AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed